BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1801327)

  • 1. Neutralization of kinin-releasing enzymes from viperid venoms by antivenom IgG fragments.
    al-Joufi A; Bailey GS; Reddi K; Smith DC
    Toxicon; 1991; 29(12):1509-11. PubMed ID: 1801327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of kinin-releasing enzymes of crotalid venoms by monospecific and polyspecific antivenoms.
    Bailey GS; al-Joufi A; Rawat S; Smith DC
    Toxicon; 1991; 29(6):777-81. PubMed ID: 1926178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of
    Kurtović T; Lang Balija M; Brvar M; Dobaja Borak M; Mateljak Lukačević S; Halassy B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity.
    Archundia IG; de Roodt AR; Ramos-Cerrillo B; Chippaux JP; Olguín-Pérez L; Alagón A; Stock RP
    Toxicon; 2011 Jun; 57(7-8):1049-56. PubMed ID: 21530569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous
    Kurtović T; Karabuva S; Grenc D; Dobaja Borak M; Križaj I; Lukšić B; Halassy B; Brvar M
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33919927
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological cross-reactivity and neutralisation of European viper venoms with the monospecific Vipera berus antivenom ViperaTAb.
    Casewell NR; Al-Abdulla I; Smith D; Coxon R; Landon J
    Toxins (Basel); 2014 Aug; 6(8):2471-82. PubMed ID: 25153254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
    León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
    Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical assessment of immunoreactivity of a new purified equine F(ab')2 against European viper venom.
    Pepin-Covatta S; Lutsch C; Lang J; Scherrmann JM
    J Pharm Sci; 1998 Feb; 87(2):221-5. PubMed ID: 9519157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraspecificity of Vipera a. ammodytes-specific antivenom towards Montivipera raddei and Macrovipera lebetina obtusa venoms.
    Kurtović T; Lang Balija M; Ayvazyan N; Halassy B
    Toxicon; 2014 Feb; 78():103-12. PubMed ID: 24378834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar effectiveness of Fab and F(ab')2 antivenoms in the neutralization of hemorrhagic activity of Vipera berus snake venom in mice.
    Lomonte B; León G; Hanson LA
    Toxicon; 1996 Oct; 34(10):1197-202. PubMed ID: 8931261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Snake F(ab')2 antivenom from hyperimmunized horse: pharmacokinetics following intravenous and intramuscular administrations in rabbits.
    Pepin S; Lutsch C; Grandgeorge M; Scherrmann JM
    Pharm Res; 1995 Oct; 12(10):1470-3. PubMed ID: 8584483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of ovine and equine antivenoms.
    Sjostrom L; al-Abdulla IH; Rawat S; Smith DC; Landon J
    Toxicon; 1994 Apr; 32(4):427-33. PubMed ID: 8052997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Snake antivenoms from hyperimmunized horses: comparison of the antivenom activity and biological properties of their whole IgG and F(ab')2 fragments.
    Morais JF; de Freitas MC; Yamaguchi IK; dos Santos MC; da Silva WD
    Toxicon; 1994 Jun; 32(6):725-34. PubMed ID: 7940578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venom-Induced Blood Disturbances by Palearctic Viperid Snakes, and Their Relative Neutralization by Antivenoms and Enzyme-Inhibitors.
    Chowdhury A; Zdenek CN; Lewin MR; Carter R; Jagar T; Ostanek E; Harjen H; Aldridge M; Soria R; Haw G; Fry BG
    Front Immunol; 2021; 12():688802. PubMed ID: 34177943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Dose of Viperfav(TM) May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation.
    Kurtović T; Brvar M; Grenc D; Lang Balija M; Križaj I; Halassy B
    Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27548220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom.
    León G; Stiles B; Alape A; Rojas G; Gutiérrez JM
    Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
    Al-Abdulla I; Casewell NR; Landon J
    J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-neutralization of thrombin-like enzymes in snake venoms by polyvalent antivenoms.
    Claus I; Mebs D
    Toxicon; 1989; 27(12):1397-9. PubMed ID: 2629180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An affinity purified ovine antivenom for the treatment of Vipera berus envenoming.
    Smith DC; Reddi KR; Laing G; Theakston RG; Landon J
    Toxicon; 1992 Aug; 30(8):865-71. PubMed ID: 1523678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.